After you submit your request, a staff member will contact you.There’s no obligation and our team is here to help you decide on a study that’s best for you.
Double-blind, placebo-controlled, phase 3 study to evaluate the efficacy and safety of plozasiran in adults with severe hypertriglyceridemia (SHASTA-3 study)